What this study is
The primary objective of the Implementation of Effective Hypertension Management Approaches: Cleveland Clinic program is to improve blood pressure control for patients diagnosed with hypertension (HTN) and uncontrolled blood pressure, specifically defined as a blood pressure greater than 150/95, across all Cleveland Clinic Northeast Ohio primary care practices. The project will scale up the availability of resources for treating hypertension in 56 primary care practices within the Cleveland Clinic Health System in Northern Ohio, reaching up to approximately 3800 patients. This project will utilize evidence from a randomized controlled trial by Margolis et al.(1) to build upon Cleveland Clinic's existing team-based primary care provider (PCP) collaboration with pharmacists and advanced practice providers (APP) and will use a mechanism that allows titrating blood pressure medications based on patient-recorded home blood pressure readings.
What's being tested
- IN-HOME BP
Intervention · OTHER
A team-based approach with a primary care provider (PCP) collaborating with pharmacists and advanced practice providers (APP) and will use a mechanism (frequent follow-up- phone or virtual appointments) that allows titrating blood pressure medications based on patient-recorded home blood pressure readings.
Study details
- Sponsor
- Anita Misra-Hebert
- Conditions
- Hypertension (HTN)
- Enrolling
- 1,520 people
- Starts
- 2026-01-06
- Est. completion
- 2029-07
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 85 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Hypertension diagnosis, aged 18-85 years old
- Uncontrolled blood pressure, defined as a blood pressure reading of > 150/95
You can't join if
- Pregnant, stage 5 chronic kidney disease, End Stage Renal Disease, enrolled in hospice care
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openCleveland Clinic
Cleveland, Ohio, United States
Recruiting
Study team
Sponsor
Anita Misra-Hebert
Study ID 25-792
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.